Biotech Austria CEO lunch

The BIOTECH AUSTRIA CEO Lunch is always a fantastic opportunity to connect and gain insights into the incredible work being done by Austrian biotech companies. This week, we had the pleasure of listening to Johannes Hackethal. The CEO and founder of THT Biomaterials GmbH shared his groundbreaking vision for the future of #tissueengineering. Johannes presented a compelling case for using human biomaterials to replace #animal study materials, highlighting the incredible potential of #human components from the placenta.

Johannes’ journey, including his distinguished Doctoral Thesis at the University of Natural Resources and Life Sciences, Vienna (BOKU), underscores his commitment to #research and development. It was inspiring to hear how THT Biomaterials is advancing the field and setting new standards. Excited for the future of biotech and the advancements on the horizon!

And thanks Peter Llewellyn-Davies, Georg Casari and Valneva to host the growing group!

#Biotech #TissueEngineering #replaceanimalmaterial #HumanCells #Placenta #Science #Innovation #Networking #AustrianBiotech #BTA